I'm afraid anything that is aimed at stopping our bodies from attacking themselves will have serious side effects. If I've read correctly and the major risks are cytopenias, infections and infusion reactions I don't think that is too bad.

The blood dyscrasias can be monitored for and I think should reverse if the med is stopped. The infection risk sadly is something that I think we will have to gamble on and just be extra carefeul with any of these 'high-power' meds, sigh. Infusion reactions again, I believe, should be fairly mild in most people and possibly treated with pre-medication or in some by stopping the medication.

All in all better than the risk of organ damage, imo. However on the flip side I don't think this study of 300+ people in the 'early stages' is all that impressive. How many of us did great in the first few years? Quite a few I'd guess. Any new advancements is good news because while it might not help all of us or even most of us if it adds another option for one of us fighting this miserable disease I give it a thumbs up.